Om

VivoSim Labs Inc. is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The company provides human-relevant toxicology insights through its new approach methodologies, including customizable NAMkind™ models designed to evaluate liver toxicity, intestinal toxicity, permeability, and related drug properties. VivoSim Labs also supports investigational toxicology, mechanism-of-action studies, predictive screening, and research services for pharmaceutical and biotechnology partners at different stages of drug development. Based in San Diego, California, VivoSim Labs plays a specialized role in preclinical testing by using complex human tissue systems to help researchers study drug behavior in a more biologically relevant environment.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I VIVOSIM LABS MED ENDAVU: Køb VivoSim Labs ($VIVS) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i VivoSim Labs, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.